🔎 Trials Near Me

Beranda › Kanker Payudara › California › Santa Rosa

Uji klinis Kanker Payudara di Santa Rosa, CA

11 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Santa Rosa (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Distance-Based Exercise to Preserve Function and Prevent Disability

Menerima peserta
  • Kaiser Permanente-Santa Rosa, Santa Rosa
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Providence Medical Foundation - Santa Rosa, Santa Rosa
  • Providence Santa Rosa Memorial Hospital, Santa Rosa
  • Saint Helena Hospital, St. Helena · 14 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Menerima pesertaFase 3
  • Providence Medical Foundation, Santa Rosa
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06377852

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Menerima pesertaFase 3
  • Providence Medical Foundation, Santa Rosa
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07174336

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Menerima pesertaFase 1/2
  • Research Site, Santa Rosa
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05123482

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Menerima pesertaFase 3
  • Kaiser Permanente-Santa Rosa, Santa Rosa
  • Providence Medical Foundation - Santa Rosa, Santa Rosa
  • Sutter Pacific Medical Foundation, Santa Rosa
  • dan 2 lainnya
Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Menerima pesertaFase 3
  • Kaiser Permanente-Santa Rosa, Santa Rosa
  • Providence Medical Foundation - Santa Rosa, Santa Rosa
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06748222

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Menerima pesertaFase 1/2
  • Providence Medical Foundation, Santa Rosa
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT05579366

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Menerima pesertaFase 3
  • Providence Medical Foundation - Santa Rosa, CA, Santa Rosa
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT05696626

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Menerima pesertaFase 3
  • Kaiser Permanente-Santa Rosa, Santa Rosa
  • Sutter Pacific Medical Foundation, Santa Rosa
  • Rohnert Park Cancer Center, Rohnert Park · 7 mi jauhnya
  • dan 1 lainnya
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Menerima pesertaStudi observasional
  • Kaiser Permanente-Santa Rosa, Santa Rosa
  • Providence Medical Foundation - Santa Rosa, Santa Rosa
  • Saint Helena Hospital, St. Helena · 14 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06418204

Uji klinis Kanker Payudara di kota lain

Studi lain di Santa Rosa

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.